|
|
|
|
Management of Recurrence of Symptoms of Gastroesophageal Reflux Disease: Synergistic Effect of Rebamipide with 15 mg Lansoprazole
Yoshida N et al.Management of Recurrence of Symptoms of Gastroesophageal Reflux Disease: Synergistic Effect of Rebamipide with 15 mg Lansoprazole.
|
|
|
My heartburn's gone - thanks to a piece of pig skin in my gut
Every year, around 180,000 hiatus hernia repair operations are carried out in Britain.Lesley Mills, 65, a housewife from Wolverhampton, underwent surgery using an implant made from pig bowel, as she tells CAROL DAVIS. THE PATIENT Around ten years ago, I...
|
|
|
Takeda announced today that it has initiated a trial to study how dexlansoprazole and several other proton pum
Takeda Global Research & Development Center, Inc., U.S., (TGRD U.S.) announced today that it has initiated a trial to study how dexlansoprazole and several other proton pump inhibitors (PPIs) affect the pharmacokinetics and pharmacodynamics of Plavix ...
|
|
|
TopAbstracts in H. Pylori/Ulcer 02/09/2010
TopAbstracts in H.Pylori/Ulcer are the abstracts most highly rated/most read by nearly 300,000 physicians who received a Doctor's Guide newsletter or visited a website Powered by Doctor's Guide in the past 28 days. Over 2000 peer-reviewed journals are...
|
|
|
Concomitant use of dexlansoprazole and other PPIs with Plavix: TGRD U.S. initiates trial
Takeda Global Research & Development Center, Inc., U.S., (TGRD U.S.) announced today that it has initiated a trial to study how dexlansoprazole and several other proton pump inhibitors (PPIs) affect the pharmacokinetics and pharmacodynamics of Plavix ...
|
|
|
Takeda Announces Initiation Of Trial To Study The Concomitant Use Of Dexlansoprazole And Other Proton Pump Inh
Takeda Global Research & Development Center, Inc., U.S., (TGRD U.S.) announced that it has initiated a trial to study how dexlansoprazole and several other proton pump inhibitors (PPIs) affect the pharmacokinetics and pharmacodynamics of Plavix (clopidogrel...
|
|
|
Takeda Announces Initiation of Trial to Study the Concomitant Use of Dexlansoprazole and Other Proton Pump Inh
DEERFIELD, Ill., Feb.9 /PRNewswire/ -- Takeda Global Research & Development Center, Inc., U.S., (TGRD U.S.) announced today that it has initiated a trial to study how dexlansoprazole and several other proton pump inhibitors (PPIs) affect the...
|
